Intravenous Immunoglobulin Therapy for Refractory Myositis.
نویسندگان
چکیده
منابع مشابه
Intravenous immunoglobulin therapy for refractory recurrent pericarditis.
Recurrent pericarditis is a troublesome complication of idiopathic acute pericarditis and occurs more frequently in pediatric patients after cardiac surgery (postpericardiotomy syndrome). Conventional treatment with nonsteroidal antiinflammatory drugs, corticosteroids, and colchicine is not always effective or may cause serious adverse effects. There is no consensus, however, on how to proceed ...
متن کاملEfficacy and Safety of intravenous immunoglobulin therapy in refractory uveitis
Abbreviations: Biologic response modifiers (BRM); Electroretinography (ERG); Fluorescein angiography (FA); Indocyanine green angiography (ICG); Intravenous Immunoglobulin (IVIg); Immunomodulatory Therapy (IMT); Optical coherence tomography (OCT); right eye (OD); Left eye (OS); Both eyes (OU); Systemic lupus erythematosus (SLE). 1Massachusetts Eye Research and Surgery Institution, Waltham, MA. E...
متن کاملIntravenous immunoglobulin therapy for Stevens-Johnson syndrome.
Stevens-Johnson syndrome (SJS) is an acute mucocutaneous disorder that can be associated with considerable morbidity. Several previous reports, all involving either adults with acquired immunodeficiency syndrome or children, suggest that intravenous immunoglobulin may be an effective treatment for SJS. We report a case of SJS in an immunocompetent adult whose condition improved dramatically aft...
متن کاملIntravenous immunoglobulin therapy for diabetic amyotrophy.
A 49-year-old woman with diabetes mellitus developed progressive weakness and atrophy of both thighs rendering her wheelchair-bound within two months. The neurological findings and electrophysiological test results were compatible with diabetic amyotrophy (DA). Immediately after intravenous immunoglobulin (IVIg) therapy (20 g x 3 days), she became able to walk with a cane. After the next course...
متن کاملIntravenous immunoglobulin therapy for Miller Fisher syndrome.
We analyzed clinical recovery of 92 patients with Miller Fisher syndrome who had been treated with IV immunoglobulin (IVIg; n = 28), plasmapheresis (n = 23), and no immune treatment (n = 41). IVIg slightly hastened the amelioration of ophthalmoplegia and ataxia, but the times of the disappearances of those symptoms were similar among three groups. In Miller Fisher syndrome, IVIg and plasmaphere...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Internal Medicine
سال: 1996
ISSN: 0918-2918,1349-7235
DOI: 10.2169/internalmedicine.35.663